Neogen shares jump after Q3 results and raised guidance
Neogen shares rose 14.1% in pre-market after reporting third-quarter 2026 results and raising its full-year revenue and adjusted EBITDA guidance.
1% in pre-market trading after the life sciences company reported third-quarter 2026 financial results and raised full-year guidance for revenue and adjusted EBITDA. According to a company press release, Neogen reported quarter results for 2026 and updated its outlook for the year.